Related Experiment Video
Updated: Jul 15, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
The structure of OMCI, a novel lipocalin inhibitor of the complement system
Pietro Roversi1, Olga Lissina, Steven Johnson
1Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, England, UK.
Abstract:
The complement (C) system is a potent innate immune defence system against parasites. We have recently characterised and expressed OmCI, a 16 kDa protein derived from the soft tick Ornithodoros moubata that specifically binds C5, thereby preventing C activation. The structure of recombinant OmCI determined at 1.9 A resolution confirms a lipocalin fold and reveals that the protein binds a fatty acid derivative that we have identified by mass spectrometry as ricinoleic acid. We propose that OmCI could sequester one of the fatty acid-derived inflammatory modulators from the host plasma, thereby interfering with the host inflammatory response to the tick bite. Mapping of sequence differences between OmCI and other tick lipocalins with different functions, combined with biochemical investigations of OmCI activity, supports the hypothesis that OmCI acts by preventing interaction with the C5 convertase, rather than by blocking the C5a cleavage site.
Insights
The complement system protein OmCI from ticks binds C5, preventing its activation and parasite defense. This protein, OmCI, may also sequester inflammatory fatty acids, dampening host responses to tick bites.
Area of Science:
- Immunology
- Parasitology
- Structural Biology
Background:
- The complement (C) system is crucial for innate immunity against parasites.
- Tick saliva contains proteins that modulate host immune responses.
Purpose of the Study:
- To characterize OmCI, a tick protein that inhibits complement activation.
- To elucidate the mechanism by which OmCI interferes with the complement system.
Main Methods:
- Protein expression and purification of OmCI.
- X-ray crystallography to determine OmCI structure.
- Mass spectrometry to identify bound molecules.
- Biochemical assays to assess complement inhibition.
Main Results:
- OmCI, a 16 kDa protein from Ornithodoros moubata, specifically binds complement C5.
- OmCI possesses a lipocalin fold and binds ricinoleic acid, a fatty acid derivative.
- OmCI prevents C5 convertase interaction, rather than blocking the C5a cleavage site.
Conclusions:
- OmCI inhibits complement activation by preventing C5 interaction with the C5 convertase.
- OmCI may modulate host inflammatory responses by sequestering fatty acid derivatives.
- OmCI represents a novel strategy employed by ticks to evade host immunity.
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Formation of Lipopolysaccharides
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Operon Model
Structure of Porins

